Form 8-K - Current report:
SEC Accession No. 0001558370-24-015714
Filing Date
2024-11-14
Accepted
2024-11-14 16:13:54
Documents
16
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K scpx-20241114x8k.htm   iXBRL 8-K 37174
2 EX-99.1 scpx-20241114xex99d1.htm EX-99.1 15046
3 GRAPHIC scpx-20241114xex99d1001.jpg GRAPHIC 12021
  Complete submission text file 0001558370-24-015714.txt   229641

Data Files

Seq Description Document Type Size
4 EX-101.SCH scpx-20241114.xsd EX-101.SCH 4321
5 EX-101.DEF scpx-20241114_def.xml EX-101.DEF 14030
6 EX-101.LAB scpx-20241114_lab.xml EX-101.LAB 20095
7 EX-101.PRE scpx-20241114_pre.xml EX-101.PRE 13692
19 EXTRACTED XBRL INSTANCE DOCUMENT scpx-20241114x8k_htm.xml XML 7387
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 241462388
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)